☰

Hermes J. Garban, Ph.D. - Publications

Affiliations: 
2000 University of California, Los Angeles, Los Angeles, CA 
Area:
Immunology, Molecular Biology, Genetics
Tree Info Grants Similar researchers PubMed Report error

44 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Givechian KB, Garner C, Garban H, Rabizadeh S, Soon-Shiong P. CAD/POLD2 gene expression is associated with poor overall survival and chemoresistance in bladder urothelial carcinoma Oncotarget. 9: 29743-29752. PMID 30038717 DOI: 10.18632/Oncotarget.25701  0.314
2018 Givechian KB, Wnuk K, Garner C, Benz S, Garban H, Rabizadeh S, Niazi K, Soon-Shiong P. Identification of an immune gene expression signature associated with favorable clinical features in Treg-enriched patient tumor samples. Npj Genomic Medicine. 3: 14. PMID 29928512 DOI: 10.1038/S41525-018-0054-7  0.38
2017 Shvartsur A, Givechian KB, Garban H, Bonavida B. Overexpression of RKIP and its cross-talk with several regulatory gene products in multiple myeloma. Journal of Experimental & Clinical Cancer Research : Cr. 36: 62. PMID 28476134 DOI: 10.1186/S13046-017-0535-Z  0.589
2016 Kaufhold S, Garbán H, Bonavida B. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication. Journal of Experimental & Clinical Cancer Research : Cr. 35: 84. PMID 27225481 DOI: 10.1186/S13046-016-0359-2  0.55
2016 Shvartsur A, Garban H, Bonavida B. Overexpression of Raf Kinase Inhibitor Protein (RKIP) in Multiple Myeloma and Its Molecular Signature Blood. 128: 5673-5673. DOI: 10.1182/Blood.V128.22.5673.5673  0.451
2016 Kaufhold S, Wottrich S, Garban H, Libra M, Bonavida B. Yin Yang 1 (YY1) Acting Primarily As an Oncogene and Rarely As a Tumor Suppressor in Distinct Hematological Malignancies: Prognostic and Therapeutic Implications Blood. 128: 5122-5122. DOI: 10.1182/Blood.V128.22.5122.5122  0.6
2015 Bonavida B, Garban H. Nitric oxide-mediated sensitization of resistant tumor cells to apoptosis by chemo-immunotherapeutics. Redox Biology. 6: 486-94. PMID 26432660 DOI: 10.1016/J.Redox.2015.08.013  0.668
2015 Hamilton N, Márquez-Garbán D, Mah V, Fernando G, Elshimali Y, Garbán H, Elashoff D, Vadgama J, Goodglick L, Pietras R. Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer. Biomed Research International. 2015: 925703. PMID 25874233 DOI: 10.1155/2015/925703  0.385
2015 Shvartsur A, Chatterjee D, Chen H, Berenson J, Garban H, Bonavida B. A Bioinformatics Approach Revealed a Differential Expression of RKIP-Related Genes in Pre-Multiple Myeloma and Multiple Myeloma: Clinical Implications Blood. 126: 5309-5309. DOI: 10.1182/Blood.V126.23.5309.5309  0.546
2015 Kaufhold S, Garban H, Bonavida B. In silico Tissue-Based Expression Analysis of YY1 and Cancer Stem Cell (CSC) Transcription Factors in Hematological Malignancies: Unraveling New Therapeutic Targets Blood. 126: 4814-4814. DOI: 10.1182/Blood.V126.23.4814.4814  0.576
2014 Agak GW, Qin M, Nobe J, Kim MH, Krutzik SR, Tristan GR, Elashoff D, Garbán HJ, Kim J. Propionibacterium acnes Induces an IL-17 Response in Acne Vulgaris that Is Regulated by Vitamin A and Vitamin D. The Journal of Investigative Dermatology. 134: 366-73. PMID 23924903 DOI: 10.1038/Jid.2013.334  0.316
2014 Qin M, Pirouz A, Kim MH, Krutzik SR, Garbán HJ, Kim J. Propionibacterium acnes Induces IL-1β secretion via the NLRP3 inflammasome in human monocytes. The Journal of Investigative Dermatology. 134: 381-8. PMID 23884315 DOI: 10.1038/Jid.2013.309  0.36
2012 Zhu W, Eng AC, Olson SY, Márquez-Garbán DC, Garbán HJ. Abstract 507: Nitrogen oxides-derived immunotherapy: Revealing cryptic melanoma-specific immune targets Cancer Research. 72: 507-507. DOI: 10.1158/1538-7445.Am2012-507  0.369
2012 Márquez-Garbán DC, Deng G, Chen H, Garbán HJ, Jung ME, Pietras RJ. Abstract 3491: Development of a new approach to kill non-small cell lung cancer cells with resistance to standard chemotherapy using parthenolide analogues Cancer Research. 72: 3491-3491. DOI: 10.1158/1538-7445.Am2012-3491  0.333
2011 Zhu W, Olson SY, Garbán H. Transcription regulator Yin-yang 1: from silence to cancer. Critical Reviews in Oncogenesis. 16: 227-38. PMID 22248056 DOI: 10.1615/Critrevoncog.V16.I3-4.60  0.355
2011 Olson SY, Chen C, Marquez DC, Bruhn KW, Craft NA, Garban HJ. Abstract 5000: Tolerogenic transcription regulator Foxp3 controls the expression of immunosuppressive cytokines in melanoma cells Cancer Research. 71: 5000-5000. DOI: 10.1158/1538-7445.Am2011-5000  0.471
2010 De Nigris F, Crudele V, Giovane A, Casamassimi A, Giordano A, Garban HJ, Cacciatore F, Pentimalli F, Marquez-Garban DC, Petrillo A, Cito L, Sommese L, Fiore A, Petrillo M, Siani A, et al. CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy Proceedings of the National Academy of Sciences of the United States of America. 107: 14484-14489. PMID 20660740 DOI: 10.1073/Pnas.1008256107  0.437
2010 Olson SY, Konishi T, Bruhn KW, Craft NA, Garban HJ. Abstract 5631: Nitric oxide-based immune response modifications: A novel paradigm in tumor vaccine development against melanoma Cancer Research. 70: 5631-5631. DOI: 10.1158/1538-7445.Am10-5631  0.305
2010 De Nigris F, Crudele V, Giovane A, Casamassimi A, Garban HJ, Marquez-Garban DC, Hayashi T, Ignarro LJ, Napoli C. Reply to Klar: Key role of YY1 in neoangiogenesis Proceedings of the National Academy of Sciences of the United States of America. 107: E191. DOI: 10.1073/Pnas.1011623108  0.374
2009 Vo DD, Prins RM, Begley JL, Donahue TR, Morris LF, Bruhn KW, de la Rocha P, Yang MY, Mok S, Garban HJ, Craft N, Economou JS, Marincola FM, Wang E, Ribas A. Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824. Cancer Research. 69: 8693-9. PMID 19861533 DOI: 10.1158/0008-5472.Can-09-1456  0.461
2009 Begley J, Vo DD, Morris LF, Bruhn KW, Prins RM, Mok S, Koya RC, Garban HJ, Comin-Anduix B, Craft N, Ribas A. Immunosensitization with a Bcl-2 small molecule inhibitor. Cancer Immunology, Immunotherapy : Cii. 58: 699-708. PMID 18807035 DOI: 10.1007/S00262-008-0592-4  0.464
2008 Olson SY, Garbán HJ. Regulation of apoptosis-related genes by nitric oxide in cancer. Nitric Oxide : Biology and Chemistry / Official Journal of the Nitric Oxide Society. 19: 170-6. PMID 18460349 DOI: 10.1016/J.Niox.2008.04.005  0.512
2007 Olson SY, Marquez DC, Ignarro LJ, Economou JS, Garban HJ. B4. Nitric oxide suppresses the expression of the tolerogenic transcription factor FOXP3 in tumor cells Nitric Oxide. 17: 17. DOI: 10.1016/J.Niox.2007.09.037  0.439
2007 Bonavida B, Garban H, Huerta-Yepez S, Vega M, Huerta S, Baritaki S. A19. Chemo and immuno-sensitizing activities of nitric oxide (NO) and reversal of tumor resistance to apoptotic stimuli: Therapeutic implications Nitric Oxide. 17: 13. DOI: 10.1016/J.Niox.2007.09.024  0.521
2006 Bonavida B, Khineche S, Huerta-Yepez S, Garbán H. Therapeutic potential of nitric oxide in cancer. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 9: 157-73. PMID 16822706 DOI: 10.1016/J.Drup.2006.05.003  0.611
2006 Huerta-Yepez S, Vega M, Garban H, Bonavida B. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis. Clinical Immunology (Orlando, Fla.). 120: 297-309. PMID 16784892 DOI: 10.1016/J.Clim.2006.03.015  0.645
2006 Schumacher LY, Vo DD, Garban HJ, Comin-Anduix B, Owens SK, Dissette VB, Glaspy JA, McBride WH, Bonavida B, Economou JS, Ribas A. Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade). Journal of Immunology (Baltimore, Md. : 1950). 176: 4757-65. PMID 16585569 DOI: 10.4049/Jimmunol.176.8.4757  0.605
2006 Gordon S, Akopyan G, Garban H, Bonavida B. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene. 25: 1125-42. PMID 16314846 DOI: 10.1038/Sj.Onc.1209080  0.622
2005 Weinberg OK, Marquez-Garban DC, Fishbein MC, Goodglick L, Garban HJ, Dubinett SM, Pietras RJ. Aromatase inhibitors in human lung cancer therapy. Cancer Research. 65: 11287-91. PMID 16357134 DOI: 10.1158/0008-5472.Can-05-2737  0.42
2005 Hongo F, Garban H, Huerta-Yepez S, Vega M, Jazirehi AR, Mizutani Y, Miki T, Bonavida B. Inhibition of the transcription factor Yin Yang 1 activity by S-nitrosation. Biochemical and Biophysical Research Communications. 336: 692-701. PMID 16143308 DOI: 10.1016/J.Bbrc.2005.08.150  0.75
2005 Vega MI, Huerta-Yepez S, Jazirehi AR, Garban H, Bonavida B. Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis. Oncogene. 24: 8114-27. PMID 16103877 DOI: 10.1038/Sj.Onc.1208954  0.754
2005 Seligson D, Horvath S, Huerta-Yepez S, Hanna S, Garban H, Roberts A, Shi T, Liu X, Chia D, Goodglick L, Bonavida B. Expression of transcription factor Yin Yang 1 in prostate cancer. International Journal of Oncology. 27: 131-41. PMID 15942652 DOI: 10.3892/Ijo.27.1.131  0.558
2005 Garbán HJ, Márquez-Garbán DC, Pietras RJ, Ignarro LJ. Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: Regulation of estrogen-dependent gene transcription Proceedings of the National Academy of Sciences of the United States of America. 102: 2632-2636. PMID 15699347 DOI: 10.1073/Pnas.0409854102  0.349
2004 Vega MI, Huerta-Yepaz S, Garban H, Jazirehi A, Emmanouilides C, Bonavida B. Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance. Oncogene. 23: 3530-40. PMID 15077178 DOI: 10.1038/Sj.Onc.1207336  0.715
2004 Garbán HJ, Buga GM, Ignarro LJ. Estrogen Receptor-Mediated Vascular Responsiveness to Nebivolol: A Novel Endothelium-Related Mechanism of Therapeutic Vasorelaxation Journal of Cardiovascular Pharmacology. 43: 638-644. PMID 15071350 DOI: 10.1097/00005344-200405000-00005  0.315
2004 Huerta-Yepez S, Vega M, Jazirehi A, Garban H, Hongo F, Cheng G, Bonavida B. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression. Oncogene. 23: 4993-5003. PMID 15048072 DOI: 10.1038/Sj.Onc.1207655  0.746
2004 Vega MI, Huerta-Yepez S, Jazirehi AR, Garban H, Bonavida B. Rituximab-Mediated Inhibition of the Transcription Repressor Yin-Yang 1 (YY1) in NHL B Cell Lines: Upregulation of Fas Expression and Sensitization to Fas-Induced Apoptosis. Blood. 104: 287-287. DOI: 10.1182/Blood.V104.11.287.287  0.751
2003 Cal C, Garban H, Jazirehi A, Yeh C, Mizutani Y, Bonavida B. Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities. Current Medicinal Chemistry. Anti-Cancer Agents. 3: 77-93. PMID 12678904  0.711
2002 Magee TR, Ferrini M, Garban HJ, Vernet D, Mitani K, Rajfer J, Gonzalez-Cadavid NF. Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase. Biology of Reproduction. 67: 20-8. PMID 12079995 DOI: 10.1093/Biolreprod/67.1.20  0.33
2001 Garbán HJ, Bonavida B. Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells. Journal of Immunology (Baltimore, Md. : 1950). 167: 75-81. PMID 11418634 DOI: 10.4049/Jimmunol.167.1.75  0.603
2001 Garbán HJ, Bonavida B. Nitric oxide disrupts H2O2-dependent activation of nuclear factor kappa B. Role in sensitization of human tumor cells to tumor necrosis factor-alpha -induced cytotoxicity. The Journal of Biological Chemistry. 276: 8918-23. PMID 11118442 DOI: 10.1074/Jbc.M008471200  0.589
1999 Garbán HJ, Bonavida B. Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis. Gynecologic Oncology. 73: 257-64. PMID 10329044 DOI: 10.1006/Gyno.1999.5374  0.608
1998 Garban H, Marquez D, Magee T, Moody J, Rajavashisth T, Rodriguez J, Hung A, Vernet D, Rajfer J, Gonzalez-Cadavid N. Cloning of Rat and Human Inducible Penile Nitric Oxide Synthase Application for Gene Therapy of Erectile Dysfunction Journal of Urology. 159: 1778-1778. DOI: 10.1097/00005392-199805000-00133  0.311
1997 Garbán H, Marquez D, Magee T, Moody J, Rajavashisth T, Rodríguez JA, Hung A, Vernet D, Rajfer J, González-Cadavid NF. Cloning of rat and human inducible penile nitric oxide synthase. Application for gene therapy of erectile dysfunction. Biology of Reproduction. 56: 954-963. PMID 9096878 DOI: 10.1095/Biolreprod56.4.954  0.34
Show low-probability matches.